Exchange: NASDAQ·Updated 07:55 PM EDT

CNXU Conexeu Sciences Inc.

$2.88
$0.07
(2.37%)
Today
Closed $2.88
$0.08
(2.78%)
After Hours
EarningsJan 22
Mkt Cap$83.21M
Vol340,884.00

About CNXU

Conexeu Sciences, Inc. engages in the development of regenerative biomaterials needed in wound care, dentistry, and aesthetics. The company was founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell on November 2, 2022 and is headquartered in Reno, NV.
42

Bearish Sentiment

How do you feel about CNXU?

Ra1nyDayz
$CNXU yesterday I received a random “information packet” in the mail from none other than the carnival clowns themselves, the Najarian Brothers. I must admit, the company sounds interesting, but there's no 10-K, and a biotech micro cap under ten bucks is dangerous. The 10-Q shows about $2.0M in cash on July 31. Operating cash burn was about $10.1M over the prior nine months, roughly $1.1M a month. That means only a couple of months of runway as of that date. The company itself states there is "substantial doubt" about its ability to keep operating for the next year. Sept 4, it raised about $1.75M, letting holders exercise warrants at $2.30. That helps, but it's small against the burn rate. An overhang of about 6.7M warrants are still outstanding, against about 28.2M shares, ~24% potential dilution. That supply tends to come in whenever the price rises. it has been paying consultants, including a "marketing consultant," in shares and has also issued insider warrants at $0.001 a share.
4
Balancedbearizback
$CNXU they’re pumping with dirty najarian brothers. Don’t trust. Read back page. Paid najarians half a million to distribute this BS
2
masonRhiiine
$CNXU Another interesting update from Conexeu...multiple scaled up batches of its CXU material met the companys specifications. Thats a useful step toward manufacturing readiness while they continue preclinical testing for Ten Minute Tissue. Still targeting Q1 2027 for the FDA 510(k) submission.
1
Amiable1
$CNXU I thought this was a promising stock that takes advantage of the GLP-1 side effects. However, I am changing my thesis. This name is manipulated. Please exercise caution.
1
Rayvio_News_Filter
$CNXU 💰 Conexeu Sciences Inc. closed an approximately $5 million private placement led by existing shareholders, management, and directors, with $250,000 of management and board subscriptions held in escrow, to support manufacturing scale-up, regulatory testing, and preclinical work toward a planned FDA 510(k) submission. Prioritized by relevance
Telemetry1129
$CNXU not sure anyone knows how low they want to take this…i do believe a lot of this volume is fake trades meant to destroy retail…the belief is this company has no $$ and will need to go to the public markets…they will get themselves situated !and then the fun will start…just my opinion!!

Advertisement|Remove ads.